APA (7th ed.) Citation

Han, R., Tan, R., Xu, L., Lin, J., Li, T., Su, H., . . . Wang, L. (2025). Activation of sclerostin inhibits Isg20-Mediated aerobic glycolysis ameliorating renal Fibrosis: The renoprotective mechanism of hederagenin in CKD. Elsevier.

Chicago Style (17th ed.) Citation

Han, Rang-yue, et al. Activation of Sclerostin Inhibits Isg20-Mediated Aerobic Glycolysis Ameliorating Renal Fibrosis: The Renoprotective Mechanism of Hederagenin in CKD. Elsevier, 2025.

MLA (9th ed.) Citation

Han, Rang-yue, et al. Activation of Sclerostin Inhibits Isg20-Mediated Aerobic Glycolysis Ameliorating Renal Fibrosis: The Renoprotective Mechanism of Hederagenin in CKD. Elsevier, 2025.

Warning: These citations may not always be 100% accurate.